These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 17235398)

  • 1. [Do we have adequate antimicrobials against methicillin-resistant Staphylococcus aureus?].
    Muñoz Bellido JL; García-Rodríguez JA
    Rev Esp Quimioter; 2006 Dec; 19(4):313-6. PubMed ID: 17235398
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals.
    McDanel JS; Perencevich EN; Diekema DJ; Herwaldt LA; Smith TC; Chrischilles EA; Dawson JD; Jiang L; Goto M; Schweizer ML
    Clin Infect Dis; 2015 Aug; 61(3):361-7. PubMed ID: 25900170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the "seesaw effect": Taking advantage of the back door left open?
    Ortwine JK; Werth BJ; Sakoulas G; Rybak MJ
    Drug Resist Updat; 2013; 16(3-5):73-9. PubMed ID: 24268586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nosocomial infection of beta-lactam antibiotic-induced vancomycin-resistant Staphylococcus aureus (BIVR).
    Hososaka Y; Hanaki H; Yanagisawa C; Yamaguchi Y; Matsui H; Nakae T; Iwata S; Hayashi I; Sunakawa K
    J Infect Chemother; 2006 Aug; 12(4):181-4. PubMed ID: 16944255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nosocomial methicillin-resistant staphylococci that remain sensitive to non-beta lactam antibiotics].
    Manfredi R; Nanetti A; Morelli S; Valentini R; Ferri M; Calza L; Chiodo F
    Recenti Prog Med; 2003; 94(7-8):344. PubMed ID: 12868245
    [No Abstract]   [Full Text] [Related]  

  • 6. Nosocomial methicillin--resistant Staphylococcus aureus with reduced susceptibility to vancomycin.
    Bhat G; Kamath S; Hussain A
    Indian J Pathol Microbiol; 2006 Apr; 49(2):311-2. PubMed ID: 16933753
    [No Abstract]   [Full Text] [Related]  

  • 7. [Epidemiology of the resistance of Staphylococcus aureus to antimicrobials].
    Cercenado Mansilla E
    Rev Esp Quimioter; 2006 Mar; 19(1):83-4. PubMed ID: 16688297
    [No Abstract]   [Full Text] [Related]  

  • 8. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy.
    Sakoulas G; Moellering RC; Eliopoulos GM
    Clin Infect Dis; 2006 Jan; 42 Suppl 1():S40-50. PubMed ID: 16323119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The killer bug.
    Shnayerson M
    Fortune; 2002 Sep; 146(6):149-50, 152, 154 passim. PubMed ID: 12360834
    [No Abstract]   [Full Text] [Related]  

  • 10. Combating resistance in a challenging, changing environment.
    Goldstein FW
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():2-6. PubMed ID: 17488370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic resistance in Staphylococcus aureus and its relevance in therapy.
    Bal AM; Gould IM
    Expert Opin Pharmacother; 2005 Oct; 6(13):2257-69. PubMed ID: 16218886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in a Tokyo hospital in 2001.
    Fujino T; Mori N; Kawana A; Naiki Y; Kawahata H; Kuratsuji T; Kudo K; Kobori O; Yazaki Y; Kirikae T
    Jpn J Infect Dis; 2001 Dec; 54(6):240-2. PubMed ID: 11862007
    [No Abstract]   [Full Text] [Related]  

  • 13. Community-acquired methicillin-resistant Staphylococcus aureus: time to address the problem.
    Malebranche DJ
    Expert Rev Anti Infect Ther; 2005 Aug; 3(4):459-61. PubMed ID: 16107190
    [No Abstract]   [Full Text] [Related]  

  • 14. Emergence of vancomycin-resistant Staphylococcus aureus identified in the Tlemcen university hospital (North-West Algeria).
    Rebiahi SA; Abdelouahid DE; Rahmoun M; Abdelali S; Azzaoui H
    Med Mal Infect; 2011 Dec; 41(12):646-51. PubMed ID: 22033230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence and spread of rifampicin-resistant, methicillin-resistant Staphylococcus aureus during vancomycin-rifampicin combination therapy in an intensive care unit.
    Ju O; Woolley M; Gordon D
    Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):61-2. PubMed ID: 16331332
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of infectious diseases due to methicillin-resistant Staphylococcus aureus (MRSA)].
    Kanno H
    Nihon Rinsho; 1990 Oct; 48(10):2355-64. PubMed ID: 2177799
    [No Abstract]   [Full Text] [Related]  

  • 17. New and emerging treatment of Staphylococcus aureus infections in the hospital setting.
    Moreillon P
    Clin Microbiol Infect; 2008 Apr; 14 Suppl 3():32-41. PubMed ID: 18318877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Update of antimicrobial resistance in Gram-positive microorganisms].
    Cercenado E
    Med Clin (Barc); 2010 Dec; 135 Suppl 3():10-5. PubMed ID: 21477699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [BIVR].
    Hanaki H
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():428-35. PubMed ID: 17455657
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular epidemiology of resistance to macrolides-lincosamides-streptogramins in methicillin-resistant Staphylococcus aureus (MRSA) causing bloodstream infections in patients admitted to Belgian hospitals.
    Denis O; Magdalena J; Deplano A; Nonhoff C; Hendrickx E; Struelens MJ
    J Antimicrob Chemother; 2002 Nov; 50(5):755-7. PubMed ID: 12407137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.